BMJ Publishing Group: New Study Supports Psilocybin's Potential as an Antidepressant
May 03, 2024
May 03, 2024
LONDON, England, May 3 (TNSres) -- BMJ Publishing Group issued the following news release about their journal "BMJ":
Psilocybin - the active ingredient in "magic" mushrooms - is a more effective treatment for symptoms of depression than controls, providing further support for its potential as an antidepressant, suggests a study published by The BMJ today.
The researchers say the findings are encouraging but "further research is needed to clarify . . .
Psilocybin - the active ingredient in "magic" mushrooms - is a more effective treatment for symptoms of depression than controls, providing further support for its potential as an antidepressant, suggests a study published by The BMJ today.
The researchers say the findings are encouraging but "further research is needed to clarify . . .